• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜肝切除术优于射频消融治疗小肝细胞癌:倾向评分匹配研究的系统评价和荟萃分析。

Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies.

机构信息

Department of Hepatobiliary Surgery, Fuzhou First Hospital Affiliated with Fujian Medical University, Fuzhou, 350009, China.

Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, China.

出版信息

Hepatol Int. 2024 Jun;18(3):998-1010. doi: 10.1007/s12072-024-10645-x. Epub 2024 Mar 14.

DOI:10.1007/s12072-024-10645-x
PMID:38480604
Abstract

BACKGROUND

The approach in small hepatocellular carcinoma (HCC) is controversial, no prospective randomized trials to compare ablative or surgical approaches. We compared the surgical and oncological outcomes after laparoscopic hepatectomy (LH) and radiofrequency ablation (RFA) in small HCC patients based on matched cohort studies that performed propensity score matching (PSM).

METHODS

We systemically searched the PubMed, Cochrane Library, Embase, Web of Science, and the Chinese BioMedical Literature (CBM) databases. All published propensity score-matched studies that compared LH and RFA for small HCC were included in this study.

RESULTS

Eight studies with a total of 1273 small HCC cases were included. The results of the meta-analysis revealed that there was no significant difference in the 1- year overall survival (OS) rate between the two groups, whereas the LH group had significantly higher 3- year overall survival rate (RR = 1.14, 95% CI 1.08-1.20, p < 0.00001) as well as 1- and 3-year disease-free survival (DFS) rates (RR = 1.31, 95% CI 1.22-1.42, p < 0.00001; RR = 1.66, 95% CI 1.46-1.90, p < 0.00001) than the RFA group. Meanwhile, the local recurrence rate and intrahepatic distant recurrence rate were significantly lower in the LH group than in the RFA group (RR = 0.29, 95% CI 0.20-0.42, p < 0.00001; RR = 0.67, 95% CI 0.49-0.92, p = 0.01). In comparison with the LH group, the RFA group had a lower incidence of overall and major postoperative complications (RR = 1.81, 95% CI 1.47-2.24, p < 0.00001; RR = 2.76, 95% CI 1.48-5.12, p = 0.001), but there was no significant difference in postoperative mortality between the two groups. In addition, further comparison of single postoperative complications showed that the incidence of ascites was lower in the RFA group than in the LH group (RR = 3.62, 95% CI 1.64-7.96, p = 0.001), whereas there was no significant difference in the incidence of postoperative bleeding, abdominal infection and bile leakage between the two groups (RR = 3.50, 95% CI 0.74-16.61, p = 0.11; RR = 5.00, 95% CI 0.59-42.23, p = 0.14; RR = 4.00, 95% CI 0.45-35.23, p = 0.21). Besides, the hospital stay was shorter in the RFA group than in the LH group (MD = 4.29, 95% CI 2.06-6.53, p = 0.0002).

CONCLUSIONS

Our meta-analysis demonstrated that in comparison with RFA in the treatment of small HCC, LH provided superior long-term OS and DFS together with lower rates of local and intrahepatic distant recurrence after surgery. However, RFA was associated with better short-term outcomes.

摘要

背景

小肝癌的治疗方法存在争议,目前尚无前瞻性随机试验比较消融或手术方法。我们通过倾向评分匹配(PSM)的匹配队列研究比较了腹腔镜肝切除术(LH)和射频消融(RFA)治疗小肝癌的手术和肿瘤学结局。

方法

我们系统地检索了 PubMed、Cochrane 图书馆、Embase、Web of Science 和中国生物医学文献数据库(CBM)。本研究纳入了所有发表的比较 LH 和 RFA 治疗小 HCC 的倾向评分匹配研究。

结果

共有 8 项研究,共纳入 1273 例小 HCC 患者。荟萃分析结果显示,两组患者 1 年总生存率(OS)率无显著差异,但 LH 组患者 3 年总生存率(RR=1.14,95%CI 1.08-1.20,p<0.00001)和 1 年、3 年无病生存率(DFS)率(RR=1.31,95%CI 1.22-1.42,p<0.00001;RR=1.66,95%CI 1.46-1.90,p<0.00001)均显著更高。同时,LH 组患者局部复发率和肝内远处复发率明显低于 RFA 组(RR=0.29,95%CI 0.20-0.42,p<0.00001;RR=0.67,95%CI 0.49-0.92,p=0.01)。与 LH 组相比,RFA 组术后总并发症和主要并发症发生率较低(RR=1.81,95%CI 1.47-2.24,p<0.00001;RR=2.76,95%CI 1.48-5.12,p=0.001),但两组术后死亡率无显著差异。此外,进一步比较单发性术后并发症显示,RFA 组患者腹水发生率低于 LH 组(RR=3.62,95%CI 1.64-7.96,p=0.001),而两组术后出血、腹部感染和胆漏发生率无显著差异(RR=3.50,95%CI 0.74-16.61,p=0.11;RR=5.00,95%CI 0.59-42.23,p=0.14;RR=4.00,95%CI 0.45-35.23,p=0.21)。此外,RFA 组患者的住院时间短于 LH 组(MD=-4.29,95%CI 2.06-6.53,p=0.0002)。

结论

本荟萃分析表明,与 RFA 治疗小肝癌相比,LH 可提供更好的长期 OS 和 DFS,同时术后局部和肝内远处复发率较低。然而,RFA 具有更好的短期预后。

相似文献

1
Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies.腹腔镜肝切除术优于射频消融治疗小肝细胞癌:倾向评分匹配研究的系统评价和荟萃分析。
Hepatol Int. 2024 Jun;18(3):998-1010. doi: 10.1007/s12072-024-10645-x. Epub 2024 Mar 14.
2
Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.比较肝切除术和射频消融术在早期肝细胞癌患者长期生存中的疗效:随机试验和高质量倾向评分匹配研究的荟萃分析。
World J Surg Oncol. 2024 Feb 19;22(1):56. doi: 10.1186/s12957-024-03330-8.
3
Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.射频消融与腹腔镜肝切除术治疗肝细胞癌的系统评价和荟萃分析。
World J Surg Oncol. 2024 Jul 24;22(1):188. doi: 10.1186/s12957-024-03473-8.
4
Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis.射频消融术与腹腔镜肝切除术治疗肝细胞癌的系统评价和荟萃分析
World J Surg Oncol. 2020 Aug 12;18(1):199. doi: 10.1186/s12957-020-01966-w.
5
Efficacy and safety of laparoscopic liver resection versus radiofrequency ablation in patients with early and small hepatocellular carcinoma: an updated meta-analysis and meta-regression of observational studies.腹腔镜肝切除术与射频消融术治疗早期小肝癌的疗效和安全性:一项观察性研究的更新荟萃分析和荟萃回归。
World J Surg Oncol. 2024 Feb 7;22(1):47. doi: 10.1186/s12957-023-03292-3.
6
Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: A real world single center study.射频消融与腹腔镜肝切除术治疗肝细胞癌:真实世界单中心研究。
Eur J Surg Oncol. 2020 Apr;46(4 Pt A):548-559. doi: 10.1016/j.ejso.2019.10.026. Epub 2019 Oct 24.
7
Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.经动脉化疗栓塞术+射频消融术与手术切除治疗肝细胞癌的比较 - 一项荟萃分析。
Eur J Surg Oncol. 2020 May;46(5):763-771. doi: 10.1016/j.ejso.2020.01.004. Epub 2020 Jan 7.
8
Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.射频消融与手术治疗血管周围型肝细胞癌:长期疗效的倾向评分分析。
J Hepatol. 2018 Jul;69(1):70-78. doi: 10.1016/j.jhep.2018.02.026. Epub 2018 Mar 8.
9
Efficacy and safety of radiofrequency ablation versus minimally invasive liver surgery for small hepatocellular carcinoma: a systematic review and meta-analysis.射频消融与微创肝切除术治疗小肝细胞癌的疗效和安全性:系统评价和荟萃分析。
Surg Endosc. 2019 Aug;33(8):2419-2429. doi: 10.1007/s00464-019-06784-0. Epub 2019 Apr 11.
10
Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.非常早期肝细胞癌手术切除与射频消融治疗的临床结局:倾向评分匹配分析。
BMC Gastroenterol. 2021 Nov 8;21(1):418. doi: 10.1186/s12876-021-01995-z.

引用本文的文献

1
Comparison of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma patients: a SEER population-based propensity score matching study.小肝细胞癌患者腹腔镜肝切除术与射频消融术的比较:一项基于监测、流行病学和最终结果(SEER)数据库人群的倾向评分匹配研究
Updates Surg. 2024 Dec;76(8):2755-2766. doi: 10.1007/s13304-024-02016-w. Epub 2024 Oct 1.
2
Is laparoscopic hepatectomy superior to radiofrequency ablation in treating small hepatocellular carcinoma?在治疗小肝细胞癌方面,腹腔镜肝切除术是否优于射频消融术?
Hepatol Int. 2024 Dec;18(6):1815-1816. doi: 10.1007/s12072-024-10724-z. Epub 2024 Aug 27.

本文引用的文献

1
Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research.射频消融术后肝细胞癌的进展:研究现状
Front Oncol. 2022 Nov 22;12:1032746. doi: 10.3389/fonc.2022.1032746. eCollection 2022.
2
Individualized Approach in the Surgical Management of Hepatocellular Carcinoma: Results from a Greek Multicentre Study.肝细胞癌外科治疗的个体化方法:一项希腊多中心研究的结果
Cancers (Basel). 2022 Sep 9;14(18):4387. doi: 10.3390/cancers14184387.
3
Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial).
手术与射频消融治疗小肝癌:一项随机对照试验(SURF试验)。
Liver Cancer. 2021 Dec 29;11(3):209-218. doi: 10.1159/000521665. eCollection 2022 Jun.
4
Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: Systematic review and meta-analysis of propensity-score matched studies.腹腔镜与开腹肝切除术治疗老年肝细胞癌的系统评价和倾向评分匹配研究的荟萃分析。
Int J Surg. 2022 Sep;105:106821. doi: 10.1016/j.ijsu.2022.106821. Epub 2022 Aug 7.
5
Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Carcinomas Smaller Than 3 cm: Analysis of Treatment Outcomes Using Propensity Score Matching.腹腔镜肝切除术与腹腔镜射频消融术治疗小于 3cm 包膜下肝细胞癌的疗效比较:倾向评分匹配分析。
Korean J Radiol. 2022 Jun;23(6):615-624. doi: 10.3348/kjr.2021.0786. Epub 2022 Mar 8.
6
Pure laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma: a propensity score and multivariate analysis.单纯腹腔镜肝切除术与经皮射频消融术治疗小肝细胞癌的倾向评分及多因素分析
Transl Cancer Res. 2022 Jan;11(1):43-51. doi: 10.21037/tcr-21-1045.
7
The effects of ultrasound-guided radiofrequency ablation and laparoscopic hepatectomy in the treatment of small hepatocellular carcinoma: a retrospective analysis.超声引导下射频消融与腹腔镜肝切除术治疗小肝癌的疗效:一项回顾性分析
Transl Cancer Res. 2021 Nov;10(11):4794-4801. doi: 10.21037/tcr-21-367.
8
Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a propensity score matching analysis.腹腔镜与开腹肝切除术治疗老年肝细胞癌的比较:倾向评分匹配分析。
HPB (Oxford). 2022 Jun;24(6):933-941. doi: 10.1016/j.hpb.2021.10.024. Epub 2021 Nov 6.
9
Non-transplantable Recurrence After Resection for Transplantable Hepatocellular Carcinoma: Implication for Upfront Treatment Choice.可移植性肝细胞癌切除术后不可移植性复发:对初始治疗选择的影响
J Gastrointest Surg. 2022 May;26(5):1021-1029. doi: 10.1007/s11605-021-05206-8. Epub 2021 Nov 19.
10
Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis.中国射频消融与腹腔镜肝切除治疗肝细胞癌的疗效:一项综合荟萃分析。
Wideochir Inne Tech Maloinwazyjne. 2021 Sep;16(3):455-471. doi: 10.5114/wiitm.2021.105377. Epub 2021 Apr 14.